Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) just unveiled an update.
Sihuan Pharmaceutical Holdings Group Ltd. has announced a positive profit alert, expecting to achieve a revenue of not less than RMB1,100 million and a net profit of not less than RMB50 million for the first half of 2025. This growth is driven by a significant increase in the medical aesthetics business, the successful commercialization of new innovative drugs, and a narrowing decline in the generic drug sector. The company has received approvals for 41 new products, which are anticipated to boost future revenue and profit growth.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group Ltd. is a company in the pharmaceutical industry, focusing on medical aesthetics and innovative drug development. The company has a strong market presence with a diverse portfolio of medical devices and pharmaceutical products, including innovative drugs and generic drugs.
Average Trading Volume: 129,308,962
Technical Sentiment Signal: Buy
Current Market Cap: HK$12.22B
See more insights into 0460 stock on TipRanks’ Stock Analysis page.